209 related articles for article (PubMed ID: 34558850)
1. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.
Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Spiezia L; Cillo U; Farinati F; Russo FP; Burra P; Senzolo M; Simioni P
Hepatol Commun; 2021 Dec; 5(12):1987-2000. PubMed ID: 34558850
[TBL] [Abstract][Full Text] [Related]
2. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.
Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M
J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575
[TBL] [Abstract][Full Text] [Related]
3. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections.
Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Burra P; Angeli P; Senzolo M; Simioni P
JHEP Rep; 2022 Jul; 4(7):100493. PubMed ID: 35647501
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M
J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications.
Zanetto A; Campello E; Pelizzaro F; Farinati F; Burra P; Simioni P; Senzolo M
Liver Int; 2022 Jun; 42(6):1229-1240. PubMed ID: 35129286
[TBL] [Abstract][Full Text] [Related]
6. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features.
Zanetto A; Rinder HM; Campello E; Saggiorato G; Deng Y; Ciarleglio M; Wilson FP; Senzolo M; Gavasso S; Bulato C; Simioni P; Garcia-Tsao G
Hepatology; 2020 Oct; 72(4):1327-1340. PubMed ID: 32614088
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
Ventura P; Venturelli G; Marcacci M; Fiorini M; Marchini S; Cuoghi C; Pietrangelo A
Thromb Res; 2016 May; 141():189-95. PubMed ID: 27065203
[TBL] [Abstract][Full Text] [Related]
8. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis.
Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Okugawa H; Yokosuka O
Scand J Gastroenterol; 2016; 51(2):236-44. PubMed ID: 26357874
[TBL] [Abstract][Full Text] [Related]
9. AGA Clinical Practice Update: Coagulation in Cirrhosis.
O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
[TBL] [Abstract][Full Text] [Related]
10. Hypercoagulability in cirrhosis: causes and consequences.
Tripodi A; Anstee QM; Sogaard KK; Primignani M; Valla DC
J Thromb Haemost; 2011 Sep; 9(9):1713-23. PubMed ID: 21729237
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic abnormalities in cirrhosis and tumor-related portal vein thrombosis.
Alkim H; Ayaz S; Sasmaz N; Oguz P; Sahin B
Clin Appl Thromb Hemost; 2012 Jul; 18(4):409-15. PubMed ID: 22166587
[TBL] [Abstract][Full Text] [Related]
12. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
Piscaglia F; Gianstefani A; Ravaioli M; Golfieri R; Cappelli A; Giampalma E; Sagrini E; Imbriaco G; Pinna AD; Bolondi L;
Liver Transpl; 2010 May; 16(5):658-67. PubMed ID: 20440775
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis.
Ren W; Zhang J; Chen Y; Wen M; Su Y; Zhao Y; Lu S; Wu J
Clin Appl Thromb Hemost; 2020; 26():1076029620982666. PubMed ID: 33356499
[TBL] [Abstract][Full Text] [Related]
14. Hypercoagulable states in patients with hepatocellular carcinoma.
Samonakis DN; Koutroubakis IE; Sfiridaki A; Malliaraki N; Antoniou P; Romanos J; Kouroumalis EA
Dig Dis Sci; 2004 May; 49(5):854-8. PubMed ID: 15259509
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis.
Campello E; Zanetto A; Spiezia L; Radu CM; Gavasso S; Ferrarese A; Farinati F; Senzolo M; Simioni P
Thromb Res; 2016 Jul; 143():118-21. PubMed ID: 27236709
[No Abstract] [Full Text] [Related]
16. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis.
Zermatten MG; Fraga M; Moradpour D; Bertaggia Calderara D; Aliotta A; Stirnimann G; De Gottardi A; Alberio L
Hepatology; 2020 Jun; 71(6):2135-2148. PubMed ID: 32090357
[TBL] [Abstract][Full Text] [Related]
17. Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma.
Zanetto A; Senzolo M; Vitale A; Cillo U; Radu C; Sartorello F; Spiezia L; Campello E; Rodriguez-Castro K; Ferrarese A; Farinati F; Burra P; Simioni P
Dig Liver Dis; 2017 Apr; 49(4):440-445. PubMed ID: 28109767
[TBL] [Abstract][Full Text] [Related]
18. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.
Sinegre T; Duron C; Lecompte T; Pereira B; Massoulier S; Lamblin G; Abergel A; Lebreton A
J Thromb Haemost; 2018 Jun; 16(6):1132-1140. PubMed ID: 29577605
[TBL] [Abstract][Full Text] [Related]
19. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis.
Sorvillo F; Mazziotti G; Carbone A; Morisco F; Cioffi M; Rotondi M; Stornaiuolo G; Amato G; Gaeta GB; Caporaso N; Carella C
Clin Endocrinol (Oxf); 2003 Feb; 58(2):207-12. PubMed ID: 12580937
[TBL] [Abstract][Full Text] [Related]
20. A study on changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma.
Park CJ; Cho HI; Kim SI
J Korean Med Sci; 1991 Mar; 6(1):1-6. PubMed ID: 1653574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
